Lisanne E. Wisse
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva.
Journal: Pharmaceutics
Published: November 04, 2025
Targeted analysis of salicylate binding partners in renal epithelial cells reveals major AMPK dependency.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: March 03, 2025
Spatial Transcriptomics Reveals Injured Cells, Signature Genes, and Communication Patterns in the Cyst Microenvironment of Polycystic Kidney Disease.
Journal: Journal of the American Society of Nephrology : JASN
Published: October 24, 2024
In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells.
Journal: International journal of molecular sciences
Published: February 16, 2024
Exploration of the skeletal phenotype of the Col1a1 +/Mov13 mouse model for haploinsufficient osteogenesis imperfecta type 1.
Journal: Frontiers in endocrinology
Published: January 15, 2023
TGF-Beta Induces Activin A Production in Dermal Fibroblasts Derived from Patients with Fibrodysplasia Ossificans Progressiva.
Journal: International journal of molecular sciences
Published: December 12, 2022
Collagen transport and related pathways in Osteogenesis Imperfecta.
Journal: Human genetics
Published: April 09, 2021
Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver.
Journal: Nutritional neuroscience
Published: November 25, 2020
Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutations.
Journal: Molecular genetics & genomic medicine
Published: May 02, 2020
Vanishing white matter: deregulated integrated stress response as therapy target.
Journal: Annals of clinical and translational neurology
Published: May 10, 2019
Last Updated: 09/26/2026